Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | GTx-186 |
Synonyms | |
Therapy Description |
GTx-186 is a multi-kinase inhibitor targeting TRKA/B/C, ROS1 fusions, ALK, and RET, potentially resulting in decreased growth of ROS1 and TRKA over expressing tumors (PMID: 24386191). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GTx-186 | ALK Inhibitor 32 RET Inhibitor 52 ROS1 Inhibitor 20 Trk Receptor Inhibitor (Pan) 31 | GTx-186 is a multi-kinase inhibitor targeting TRKA/B/C, ROS1 fusions, ALK, and RET, potentially resulting in decreased growth of ROS1 and TRKA over expressing tumors (PMID: 24386191). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|